[Elsevier] Alectinib versus crizotinib in patients with ALK-positive non-small-cell lung cancer (J-ALEX): an open-label, randomised phase 3 trial |
Reward10points
Best Answer |
| |
post
reply
points
385
10
All-purpose redox-active metal-organic frameworks as both cathodic and anodic host materials for advanced lithium-sulfur batteries
10
Early Rhythm Control and Incident Dementia in Patients With Atrial Fibrillation and Prior Stroke
10
Rhythm vs Rate Control Strategy for Atrial Fibrillation
10
The equilibrium-point hypothesis: A major framework for the understanding of action and perception
10
Green synthesis of reduced graphene oxide with multiple environmental applications
